Judith Bell, BSc

Senior Associate, Value & Access

Office Location

Manchester, United Kingdom

BSc, Biomedical Sciences
The University of Manchester, Manchester, United Kingdom

Judith Bell has over 7 years of experience in conducting systematic and targeted reviews for a range of purposes including health technology assessment submissions and publications. Ms. Bell has experience in a range of therapeutic areas including autoimmune diseases, dermatology, diabetes, oncology, and rare diseases. Ms. Bell has experience in both leading and overseeing project management for systematic literature reviews.

Send Judith Bell a message

Full Name

Business Title

Organization

Technical Area

Attachments

You may attach up to three PDF, Word or Excel documents.

Each document must be under 2 MB.

Maximum 3 files.
2 MB limit.
Allowed types: pdf doc docx xls xlsx txt.

Your message

Yes, I would like to receive updates on RTI-HS news, information, and events.

By submitting this form, you accept the RTI-HS privacy policy.

Selected Recent Publications

Yousif Z, Schultz BG, Candela N, Harold S, Bell J, Turpin R, Hartley L. Systematic literature review to evaluate randomized clinical trials of advanced therapies for moderate to severe crohn's disease. Poster presented at the ISPOR 2023 Conference; May 6, 2023. Boston, MA. [abstract] Value Health. 2023 Jun; 26(6 supplement):S15. doi: 10.1016/j.jval.2023.03.085

Saidha S, Bell J, Harold S, Belisario JM, Hawe E, Shao Q, Wyse K, Maiese EM. Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis. Neurol Sci. 2023 May;44(5):1515-32. doi: 10.1007/s10072-022-06582-y

Yucel E, Hartley L, Bell J, Wolowacz S, Kamgar F, Hawe E. A systematic literature review of utility estimates for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL). Poster presented at the ISPOR Europe 2022; November 6, 2022. Vienna, Austria. [abstract] Value Health. 2022 Dec 1; 25(12):S395. doi: 10.1016/j.jval.2022.09.1964

Saidha S, Bell J, Harold SE, Marcano Belisario JS, Hawe E, Shao Q, Wyse K, Maiese EM. A systematic literature review of immunoglobulin levels among B-cell–depleting therapies and risk of infections in relapsing multiple sclerosis. Poster presented at the 2022 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting; June 1, 2022. National Harbor, MD.

More Publications

Judith Bell, BSc

Senior Associate, Value & Access

Send Judith Bell a message

How Can We Help You?